Cargando…

Impact of kidney function and kidney volume on intracranial aneurysms in patients with autosomal dominant polycystic kidney disease

Presently, only personal or family history of intracranial aneurysm/subarachnoid hemorrhage (IA/SAH) has been established as a risk factor for IA in autosomal dominant polycystic kidney disease (ADPKD). This study aimed to verify the association between kidney function/volume and IAs in patients wit...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kataoka, Hiroshi, Akagawa, Hiroyuki, Yoshida, Rie, Iwasa, Naomi, Ushio, Yusuke, Akihisa, Taro, Sato, Masayo, Manabe, Shun, Makabe, Shiho, Kawachi, Keiko, Hoshino, Junichi, Tsuchiya, Ken, Nitta, Kosaku, Mochizuki, Toshio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9613770/ https://www.ncbi.nlm.nih.gov/pubmed/36302803 http://dx.doi.org/10.1038/s41598-022-22884-9

Ejemplares similares

Prediction of Renal Prognosis in Patients with Autosomal Dominant Polycystic Kidney Disease Using PKD1/PKD2 Mutations
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

High Serum Phosphate Level as a Risk Factor to Determine Renal Prognosis in Autosomal Dominant Polycystic Kidney Disease: A Retrospective Study
por: Sato, Masayo, et al.
Publicado: (2020)

Germline Mutations for Kidney Volume in ADPKD
por: Kataoka, Hiroshi, et al.
Publicado: (2021)

Autosomal Dominant Polycystic Kidney Disease with Emphysematous Polycystic Renal Infection That Required Surgical Treatment
por: Watanabe, Kentaro, et al.
Publicado: (2018)

Visceral to subcutaneous fat ratio as an indicator of a ≥30% eGFR decline in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Sex Differences in Time-Series Changes in Pseudo-R(2) Values Regarding Hyperuricemia in Relation to the Kidney Prognosis
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Urinary Aquaporin 2 as a Potential Indicator Predicting Tolvaptan Response in Patients With ADPKD
por: Makabe, Shiho, et al.
Publicado: (2021)

Machine learning for morbid glomerular hypertrophy
por: Ushio, Yusuke, et al.
Publicado: (2022)

Maximum Carotid Intima-Media Thickness in Association with Renal Outcomes
por: Manabe, Shun, et al.
Publicado: (2021)

Cystic Kidney Diseases That Require a Differential Diagnosis from Autosomal Dominant Polycystic Kidney Disease (ADPKD)
por: Sekine, Akinari, et al.
Publicado: (2022)

Maximum Glomerular Diameter and Oxford MEST-C Score in IgA Nephropathy: The Significance of Time-Series Changes in Pseudo-R(2) Values in Relation to Renal Outcomes
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Glomerular Basement Membrane Protein Expression and the Diagnosis and Prognosis of Autosomal Dominant Alport Syndrome
por: Akihisa, Taro, et al.
Publicado: (2019)

Impacts of Sex Differences in Pulse Pressure among Patients with Chronic Kidney Disease
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Urinary Mulberry Cells as a Biomarker of the Efficacy of Enzyme Replacement Therapy for Fabry Disease
por: Aoyama, Yumi, et al.
Publicado: (2020)

Time series changes in pseudo-R(2) values regarding maximum glomerular diameter and the Oxford MEST-C score in patients with IgA nephropathy: A long-term follow-up study
por: Kataoka, Hiroshi, et al.
Publicado: (2020)

Visceral fat and attribute-based medicine in chronic kidney disease
por: Kataoka, Hiroshi, et al.
Publicado: (2023)

Umbilical hernia in autosomal dominant polycystic kidney disease
por: Hattori, Yoshinari, et al.
Publicado: (2014)

Renal disease progression in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2012)

Autosomal dominant polycystic kidney
por: Gudadhe, Rugaved Raghavendra, et al.
Publicado: (2022)

Changes in Kidney and Liver Volumes in Patients With Autosomal Dominant Polycystic Kidney Disease Before and After Dialysis Initiation
por: Suwabe, Tatsuya, et al.
Publicado: (2023)

Autosomal Recessive Polycystic Kidney Disease
por: Salati, Sajad Ahmad
Publicado: (2014)

Autosomal Recessive Polycystic Kidney Disease
por: Hafer, Ashley S., et al.
Publicado: (2017)

Kidney volume and function in autosomal dominant polycystic kidney disease
por: Higashihara, Eiji, et al.
Publicado: (2013)

Change in kidney volume after kidney transplantation in patients with autosomal polycystic kidney disease
por: Veroux, Massimiliano, et al.
Publicado: (2018)

PKD1 mutation may epistatically ameliorate nephronophthisis progression in patients with NPHP1 deletion
por: Watanabe, Saki, et al.
Publicado: (2019)

Autosomal dominant polycystic kidney disease in Colombia
por: Camargo, Jessica T., et al.
Publicado: (2023)

Successful entecavir plus prednisolone treatment for hepatitis B virus-associated membranoproliferative glomerulonephritis: A case report
por: Kataoka, Hiroshi, et al.
Publicado: (2019)

Molecular genetic analysis of polycystic kidney disease 1 and polycystic kidney disease 2 mutations in pedigrees with autosomal dominant polycystic kidney disease
por: Bitarafan, Fatemeh, et al.
Publicado: (2019)

Tolvaptan for Primary Aldosteronism and Autosomal Dominant Polycystic Kidney Disease: A Case Report
por: Kunizawa, Kyohei, et al.
Publicado: (2018)

Myeloperoxidase-antineutrophil cytoplasmic antibody-associated crescentic glomerulonephritis in autosomal dominant polycystic kidney disease
por: Sumida, Keiichi, et al.
Publicado: (2013)

Trends in the Management and Outcomes of Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease
por: Patel, Madhukar S., et al.
Publicado: (2014)

Autosomal dominant polycystic kidney disease with ectopic unilateral multicystic dysplastic kidney
por: Xu, Jing, et al.
Publicado: (2013)

Serum bicarbonate is associated with kidney outcomes in autosomal dominant polycystic kidney disease
por: Blijdorp, Charles J, et al.
Publicado: (2020)

Phase Separation in Kidney Diseases: Autosomal Dominant Polycystic Kidney Disease and Beyond
por: Zhang, Lirong, et al.
Publicado: (2023)

Tesevatinib ameliorates progression of polycystic kidney disease in rodent models of autosomal recessive polycystic kidney disease
por: Sweeney, William E, et al.
Publicado: (2017)

Switching from allopurinol to febuxostat for the treatment of hyperuricemia and renal function in patients with chronic kidney disease
por: Tsuruta, Yuki, et al.
Publicado: (2014)

Management of Osteoporosis in Chronic Kidney Disease
por: Nitta, Kosaku, et al.
Publicado: (2017)

Paraneoplastic Polymyositis Due to Renal Cell Carcinoma in a Patient with Autosomal Dominant Polycystic Kidney Disease
por: Noda-Narita, Shoko, et al.
Publicado: (2021)

Recurrent Cholangitis in a Patient with Autosomal Dominant Polycystic Kidney Disease (ADPKD) and Caroli's Disease
por: Hasegawa, Eiko, et al.
Publicado: (2016)

Developments in the management of autosomal dominant polycystic kidney disease
por: Masoumi, Amirali, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_uvoegdi32040r0oqd6tgk8h5gf